← All decks

Dermatology

Mastocytosis

Built from Dermatology, 5th Edition

What’s inside

10 sections · 83 slides

  1. 01

    Overview

    • What this chapter covers
    • 50-70%
    • Clinical presentations of childhood and adult-onset mastocytosis

    3 slides

  2. 02

    History and Epidemiology

    From the first case report to who develops mastocytosis today

    • What is mastocytosis
    • A short history
    • Who gets mastocytosis, and when
    • Family patterns

    4 slides

  3. 03

    Pathogenesis

    Mast cell biology and the KIT gene changes that drive disease

    • How a mast cell matures
    • KIT and its trigger, stem cell factor
    • KIT mutations drive mastocytosis
    • The same mutation, very different results
    • From mutation to symptoms

    5 slides

  4. 04

    Cutaneous Mastocytosis in Children

    Mastocytomas, maculopapular disease, and diffuse skin involvement

    • Symptoms from mast cell chemicals
    • Mast cell mediators and associated symptoms of mastocytosis
    • Three childhood skin patterns
    • Mastocytomas
    • Mastocytomas in young children
    • Mastocytoma with blistering and erosion
    • Mastocytomas in infants
    • Bullae in a mastocytoma
    • Multiple-lesion (maculopapular) disease in children
    • Maculopapular cutaneous mastocytosis in children
    • Maculopapular cutaneous mastocytosis in children
    • Diffuse cutaneous mastocytosis
    • Diffuse cutaneous mastocytosis and blistering in infants
    • Diffuse cutaneous mastocytosis
    • Diffuse cutaneous mastocytosis with vesicles and erosions
    • Blistering in young children

    16 slides

  5. 05

    Cutaneous Mastocytosis in Adults

    Urticaria pigmentosa, TMEP, and the Darier sign

    • Adult skin disease: "urticaria pigmentosa"
    • Adult maculopapular mastocytosis ("urticaria pigmentosa")
    • Adult maculopapular mastocytosis ("urticaria pigmentosa")
    • Adult maculopapular mastocytosis with a normal serum tryptase level
    • Less common adult patterns
    • Telangiectasia macularis eruptiva perstans (TMEP)
    • Telangiectasia macularis eruptiva perstans
    • The Darier sign
    • Darier sign in mastocytosis
    • Childhood-onset versus adult-onset disease

    10 slides

  6. 06

    Systemic Manifestations

    How mastocytosis can affect bone, marrow, spleen, gut, liver, and brain

    • Bone involvement
    • How mast cells affect bone
    • Bone marrow, spleen, and lymph nodes
    • Gut, liver, and brain effects

    4 slides

  7. 07

    Classification of Mastocytosis

    The WHO scheme, systemic mastocytosis subtypes, and evaluating a new patient

    • The WHO classification, at a glance
    • The WHO classification system
    • WHO 2016 classification of mastocytosis
    • Diagnosing systemic mastocytosis
    • WHO criteria for the diagnosis of systemic mastocytosis (SM) and related B &C findings
    • WHO criteria for the diagnosis of systemic mastocytosis (SM) and related B &C findings (continued)
    • WHO criteria for the diagnosis of systemic mastocytosis (SM) and related B &C findings (continued)
    • Indolent systemic mastocytosis (ISM)
    • Smoldering SM and SM with a blood neoplasm
    • Aggressive SM and mast cell leukemia
    • Survival of patients with systemic mastocytosis
    • Extra gene mutations affect outlook
    • Evaluating a child with skin lesions
    • Evaluation of a patient with cutaneous lesions of mastocytosis
    • Evaluating an adult with skin lesions

    15 slides

  8. 08

    Pathology and Laboratory Findings

    Skin biopsy findings, special stains, and blood tests like tryptase

    • What a skin biopsy shows
    • Special stains to detect dermal mast cells
    • How dense are the mast cells
    • Blood and urine tests (indirect evidence)

    4 slides

  9. 09

    Differential Diagnosis

    Conditions that can look like mastocytosis at different ages

    • Mimics in children
    • Mimics in adults, and mast cell activation syndrome

    2 slides

  10. 10

    Treatment

    Trigger avoidance, symptom control, and drugs that target KIT

    • Avoiding triggers
    • Therapeutic ladder for mastocytosis
    • Therapeutic ladder for mastocytosis (continued)
    • Therapeutic ladder for mastocytosis (continued)
    • Antihistamines: first-line symptom control
    • Cromolyn, phototherapy, and corticosteroids
    • Emergency treatment and omalizumab
    • Tyrosine kinase inhibitors for advanced disease
    • Other advanced therapies
    • Key take-home points
    • References
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • References (continued)
    • Dermatology, 5th Edition (2-Volume Set)

    20 slides